European inhaler market was valued at around $6.4 billion in 2018 and is anticipated to grow at a substantial rate of 2.3% during the forecast period. Major countries that will contribute to the inhaler market within the region includes UK, Germany, France, Italy and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the inhaler market.
Related posts:
- 2 Nights 3 Days Golden Triangle Tour
- CBG Hemp Flower Jack Frost 3.5g | Buy CBG Hemp Flower Buds | CBD
- Lookna Launched a New Mobile Search App Designed for People Looking for Taxi
- Business Banking In An Instant — Sandeep Bakhshi, ICICI Bank
- Business Email List | Business Industry Database | Business Leads
- Masters In Hospital Administration | MHA | AIHMS
- Best tips to improve your mobile app performance
- Tax law courses learn online | Online classes for Tax law | Top online courses in Tax law
- python mobile app development
- Category 8 Cable Will Assume Noteworthy Part In 25G & 40G Server Farm Ethernet
- Category: Health
- Tags: future prospects, industry growth, opportunities, share, size